The Production of Ac-225

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|11|3|173-179

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.11, Iss.3, 2018-12, pp. : 173-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 156-172

Bentham Science Publishers

Access to resources Recommend Favorite

In vivo Evaluation of [225Ac]Ac-DOTAZOL for α-Therapy of Bone Metastases

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 223-230

Bentham Science Publishers

Access to resources Recommend Favorite

NorthStar Perspectives for Actinium-225 Production at Commercial Scale

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 180-191

Bentham Science Publishers

Access to resources Recommend Favorite

The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 154-155

Bentham Science Publishers

Access to resources Recommend Favorite

Actinium-225 in Targeted Alpha-Particle Therapeutic Applications

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 4, 2011-10 ,pp. : 306-320

Bentham Science Publishers

Access to resources Recommend Favorite